Drug ID: | NPD1695 |
Drug Name: | |
Molecular Formula: | C15H18O3 |
Canonical SMILES: | CC1=CC[C@]23[C@@H]1[C@H]1OC(=O)C(=C)[C@@H]1CC[C@@]3(O2)C |
Standard InCHI: | InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11-,12-,14-,15+/m0/s1 |
Standard InCHIKey: | UVJYAKBJSGRTHA-ZCRGAIPPSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001386 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 636760 |
ChEBI | |
CAS Number |
Molecular Weight | 246.13 |
ALogP | 1.2334 |
MLogP | 2.78 |
XLogP | 1.47 |
HDA | 3 |
HBD | 0 |
Rotatable Bonds | 2 |
TPSA | 38.83 |
RO5 Violation | 0 |